Jcovden

E854995

Jcovden is the brand name of Johnson & Johnson’s single-dose COVID-19 vaccine based on an adenovirus vector platform.

All labels observed (1)

Label Occurrences
Jcovden canonical 1

How this entity was disambiguated

Statements (49)

Predicate Object
instanceOf COVID-19 vaccine ⓘ
pharmaceutical product ⓘ
vaccine ⓘ
administeredAs 0.5 mL intramuscular dose ⓘ
authorizationType Emergency Use Authorization in the United States ⓘ
conditional marketing authorization in the European Union ⓘ
belongsToCompany Johnson & Johnson ⓘ
belongsToTherapeuticArea infectious disease ⓘ
vaccinology ⓘ
brandNameOf Ad26.COV2.S ⓘ
containsGeneticMaterialFor SARS-CoV-2 spike glycoprotein ⓘ
developedBy Janssen Pharmaceuticals ⓘ
Janssen Vaccines ⓘ
Johnson & Johnson ⓘ
developedDuring COVID-19 pandemic ⓘ
doseRegimen single-dose primary vaccination ⓘ
hasActiveSubstance recombinant, replication-incompetent human adenovirus type 26 vector encoding the SARS-CoV-2 spike protein ⓘ
hasAdverseEffects fatigue ⓘ
fever ⓘ
headache ⓘ
injection site pain ⓘ
myalgia ⓘ
hasAlternativeName Ad26.COV2.S ⓘ
Johnson & Johnson COVID-19 Vaccine ⓘ
hasATCCode J07BX03 ⓘ
hasCommonName Janssen COVID-19 Vaccine ⓘ
hasManufacturer Janssen Pharmaceuticals ⓘ
Johnson & Johnson ⓘ
hasRegulatoryStatus received Emergency Use Authorization from the U.S. Food and Drug Administration ⓘ
received conditional marketing authorization from the European Medicines Agency ⓘ
hasSeriousAdverseEffects Guillain–Barré syndrome ⓘ
anaphylaxis ⓘ
thrombosis with thrombocytopenia syndrome ⓘ
indicatedFor prevention of COVID-19 ⓘ
indicatedPopulation adults ⓘ
injectionSite deltoid muscle of the upper arm ⓘ
ismRNA false ⓘ
isPartOf global COVID-19 vaccination campaigns ⓘ
isSingleDose true ⓘ
pharmaceuticalForm suspension for injection ⓘ
regulatoryLabelIncludesWarningFor Guillain–Barré syndrome ⓘ
thrombosis with thrombocytopenia syndrome ⓘ
routeOfAdministration intramuscular injection ⓘ
storageTemperature refrigerated conditions (2–8 °C) ⓘ
targetsDisease COVID-19 ⓘ
linked to: COVID-19 pandemic
targetsVirus SARS-CoV-2 ⓘ
vaccinePlatform adenoviral vector vaccine ⓘ
viral vector vaccine ⓘ
vectorType human adenovirus serotype 26 ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Ad26.COV2.S → brandName → Jcovden ⓘ